ClinicalTrials.Veeva

Menu

Segmentectomy for Solid-dominant Lung Cancer

Fudan University logo

Fudan University

Status and phase

Enrolling
Phase 3

Conditions

Lung Adenocarcinoma
Segmentectomy

Treatments

Procedure: Segmentectomy

Study type

Interventional

Funder types

Other

Identifiers

NCT06634966
ECTOP-1025

Details and patient eligibility

About

This is a clinical trial from Eastern Cooperative Thoracic Oncology Project (ECTOP), numbered as ECTOP-1025. The goal of this clinical trial is to confirm the theraputic effect of segmentectomy for solid-dominant invasive lung cancer with size of 2-3cm. The main questions it aims to answer are:

  • The 5-year disease-free survival of patients having solid-dominant invasive lung cancer with size of 2-3cm;
  • The post-operative lung function tests after receiving segmentectomy. Participants will receive segmentectomy as the surgical procedure.

Enrollment

277 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients who sign the informed consent form and are willing to complete the study according to the plan;
  • Aged from 18 to 80 years old;
  • ECOG equals 0 or 1;
  • Not receiving lung cancer surgery before;
  • Confirmed to be invasive lung adenocarcinoma intraoperatively or postoperatively;
  • Ground glass-dominant lung nodules
  • Consolidation-to-tumor ratio (CTR) ranges from 0.5 to 1, and tumor size ranges from 2 to 3cm;
  • cN0 without distant metastasis;
  • Tumors could be completely resected assed by surgeons;
  • Not receiving chemotherapy or radiotherapy before.

Exclusion criteria

  • CTR is not 0.5-1, or size is not 2-3cm;
  • Tumors could not be completely resected assed by surgeons;
  • Not lung adenocarcinoma diagnosed cytologically or pathologically;
  • Receiving lung cancer surgery before;
  • Receiving radiotherapy or chemotherapy.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

277 participants in 1 patient group

Segmentectomy
Experimental group
Description:
Segmentectomy is performed for solid-dominant invasive lung cancer with size of 2-3cm.
Treatment:
Procedure: Segmentectomy

Trial contacts and locations

1

Loading...

Central trial contact

Fangqiu Fu, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems